PSNL
Personalis Inc

2,674
Mkt Cap
$711.32M
Volume
1.03M
52W High
$10.95
52W Low
$2.83
PE Ratio
-9.14
PSNL Fundamentals
Price
$7.60
Prev Close
$8.01
Open
$7.93
50D MA
$7.54
Beta
2.30
Avg. Volume
1.24M
EPS (Annual)
-$1.37
P/B
4.15
Rev/Employee
$369,493.45
Loading...
Loading...
News
all
press releases
Morgan Stanley Issues Positive Forecast for Personalis (NASDAQ:PSNL) Stock Price
Morgan Stanley upped their price target on shares of Personalis from $5.00 to $9.00 and gave the company an "equal weight" rating in a report on Tuesday...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Guggenheim Issues Positive Forecast for Personalis (NASDAQ:PSNL) Stock Price
Guggenheim lifted their target price on Personalis from $6.00 to $12.00 and gave the company a "buy" rating in a report on Tuesday...
MarketBeat·1d ago
News Placeholder
BTIG Research Forecasts Strong Price Appreciation for Personalis (NASDAQ:PSNL) Stock
BTIG Research boosted their target price on shares of Personalis from $11.00 to $12.00 and gave the stock a "buy" rating in a research note on Tuesday...
MarketBeat·1d ago
News Placeholder
Personalis (NASDAQ:PSNL) Shares Gap Up - Here's What Happened
Personalis (NASDAQ:PSNL) Shares Gap Up - Time to Buy...
MarketBeat·2d ago
News Placeholder
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal test for surveillance of cancer recurrence...
Business Wire·3d ago
News Placeholder
FY2025 EPS Estimates for Personalis Boosted by HC Wainwright
Personalis, Inc. (NASDAQ:PSNL - Free Report) - Research analysts at HC Wainwright raised their FY2025 EPS estimates for shares of Personalis in a note issued to investors on Thursday, November 6th...
MarketBeat·4d ago
News Placeholder
Personalis (NASDAQ:PSNL) CEO Christopher Hall Sells 29,612 Shares
Personalis, Inc. (NASDAQ:PSNL - Get Free Report) CEO Christopher Hall sold 29,612 shares of the business's stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of...
MarketBeat·7d ago
News Placeholder
Personalis (NASDAQ:PSNL) Shares Gap Down - Should You Sell?
Personalis (NASDAQ:PSNL) Shares Gap Down - What's Next...
MarketBeat·7d ago
News Placeholder
Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates
Personalis (PSNL) delivered earnings and revenue surprises of +14.29% and +5.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Personalis Reports Third Quarter 2025 Financial Results
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the third quarter ended September 30, 2025. The quarter was distinguished...
Business Wire·9d ago

Latest PSNL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.